Early Investigation of Glucose Monitoring After Gestational Diabetes Pilot

Launched by OHIO STATE UNIVERSITY · Dec 27, 2023

Keywords

ClinConnect Summary

This clinical trial is studying how continuous glucose monitors (CGM) can help women who had gestational diabetes (GDM) after they give birth. Gestational diabetes is a type of diabetes that occurs during pregnancy, and research shows that about one-third of these women may have high blood sugar levels within three years after having their baby. The goal of the study is to see if using a CGM, which is a small device placed under the skin to track blood sugar levels, can help identify those at risk for developing diabetes after pregnancy. Participants will wear the CGM for a few weeks after delivery and answer questions about how they felt using it.

To be eligible for this study, you need to be a woman who recently gave birth and had gestational diabetes during your pregnancy. You also need to be able to understand the study and give consent in English. Unfortunately, if you had diabetes before pregnancy, are using certain diabetes medications right after delivery, or had a preterm birth, you would not be eligible to participate. If you join the study, you can expect to wear the CGM for a short time and share your experience, which could help researchers understand if this method is beneficial for follow-up care for women with a history of gestational diabetes.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Women with a viable singleton intrauterine pregnancy
• • Able to understand the study, and having understood, provide written informed consent in English
• • Recent pregnancy affected by gestational diabetes
• Exclusion Criteria:
• • Pregestational Diabetes (Type I or Type II)
• • Continued use of diabetes medications (including metformin and insulin) immediately after delivery
• • Preterm delivery (\< 37 weeks gestation)
• • Twin or higher order gestation
• • No access to a smartphone
• • Unable or unwilling to wear CGM or return for follow up at postpartum mother-infant dyad clinic
• • Participation in this trial in a prior pregnancy
• • History of skin allergy to adhesive products or CGM